Open‐label study with the monoamine stabilizer (‐)‐OSU6162 in myalgic encephalomyelitis/chronic fatigue syndrome,Brain and Behavior

当前位置： X-MOL 学术 › Brain Behav. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Open‐label study with the monoamine stabilizer (‐)‐OSU6162 in myalgic encephalomyelitis/chronic fatigue syndrome
Brain and Behavior ( IF 2.6 ) Pub Date : 2021-02-02 , DOI: 10.1002/brb3.2040
Sara Haghighi ₁ , Sara Forsmark ₂ , Olof Zachrisson ₂ , Arvid Carlsson ₃ , Marie K L Nilsson ₃ , Maria L Carlsson ₃ , Robert C Schuit ₄ , Carl-Gerhard Gottfries ₂

Affiliation

The purpose of the present study was to investigate the safety and tolerability of the monoaminergic stabilizer (‐)‐OSU6162 in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). In addition, a potential therapeutic effect of (‐)‐OSU6162 in ME/CFS was evaluated by means of observer‐rated scales and self‐assessment rating scales.

中文翻译：

单胺稳定剂 (-)-OSU6162 在肌痛性脑脊髓炎/慢性疲劳综合征中的开放标签研究

本研究的目的是研究单胺能稳定剂 (‐)-OSU6162 在肌痛性脑脊髓炎/慢性疲劳综合征 (ME/CFS) 患者中的安全性和耐受性。此外，通过观察者评定量表和自我评估评定量表评估了 (-)-OSU6162 在 ME/CFS 中的潜在治疗效果。

更新日期：2021-04-11

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11